Report Detail

Other Global Breast Cancer Treatment Market Size, Status and Forecast 2019-2025

  • RnM3462751
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Breast Cancer Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Chemotherapy
      • 1.4.3 Radiation Therapy
      • 1.4.4 Biologic Targeted Therapy
      • 1.4.5 Breast Surgery
      • 1.4.6 Hormone Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Breast Cancer Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Ambulatory Care Units
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Breast Cancer Treatment Market Size
    • 2.2 Breast Cancer Treatment Growth Trends by Regions
      • 2.2.1 Breast Cancer Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Breast Cancer Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Breast Cancer Treatment Market Size by Manufacturers
      • 3.1.1 Global Breast Cancer Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Breast Cancer Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Breast Cancer Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Breast Cancer Treatment Key Players Head office and Area Served
    • 3.3 Key Players Breast Cancer Treatment Product/Solution/Service
    • 3.4 Date of Enter into Breast Cancer Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Breast Cancer Treatment Market Size by Type (2014-2019)
    • 4.2 Global Breast Cancer Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Breast Cancer Treatment Market Size (2014-2019)
    • 5.2 Breast Cancer Treatment Key Players in United States
    • 5.3 United States Breast Cancer Treatment Market Size by Type
    • 5.4 United States Breast Cancer Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Breast Cancer Treatment Market Size (2014-2019)
    • 6.2 Breast Cancer Treatment Key Players in Europe
    • 6.3 Europe Breast Cancer Treatment Market Size by Type
    • 6.4 Europe Breast Cancer Treatment Market Size by Application

    7 China

    • 7.1 China Breast Cancer Treatment Market Size (2014-2019)
    • 7.2 Breast Cancer Treatment Key Players in China
    • 7.3 China Breast Cancer Treatment Market Size by Type
    • 7.4 China Breast Cancer Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Breast Cancer Treatment Market Size (2014-2019)
    • 8.2 Breast Cancer Treatment Key Players in Japan
    • 8.3 Japan Breast Cancer Treatment Market Size by Type
    • 8.4 Japan Breast Cancer Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Breast Cancer Treatment Market Size (2014-2019)
    • 9.2 Breast Cancer Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Breast Cancer Treatment Market Size by Type
    • 9.4 Southeast Asia Breast Cancer Treatment Market Size by Application

    10 India

    • 10.1 India Breast Cancer Treatment Market Size (2014-2019)
    • 10.2 Breast Cancer Treatment Key Players in India
    • 10.3 India Breast Cancer Treatment Market Size by Type
    • 10.4 India Breast Cancer Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Breast Cancer Treatment Market Size (2014-2019)
    • 11.2 Breast Cancer Treatment Key Players in Central & South America
    • 11.3 Central & South America Breast Cancer Treatment Market Size by Type
    • 11.4 Central & South America Breast Cancer Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 F. Hoffmann-La Roche
      • 12.1.1 F. Hoffmann-La Roche Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Breast Cancer Treatment Introduction
      • 12.1.4 F. Hoffmann-La Roche Revenue in Breast Cancer Treatment Business (2014-2019)
      • 12.1.5 F. Hoffmann-La Roche Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Breast Cancer Treatment Introduction
      • 12.2.4 Novartis Revenue in Breast Cancer Treatment Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 Merck
      • 12.3.1 Merck Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Breast Cancer Treatment Introduction
      • 12.3.4 Merck Revenue in Breast Cancer Treatment Business (2014-2019)
      • 12.3.5 Merck Recent Development
    • 12.4 Eli Lilly and Company
      • 12.4.1 Eli Lilly and Company Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Breast Cancer Treatment Introduction
      • 12.4.4 Eli Lilly and Company Revenue in Breast Cancer Treatment Business (2014-2019)
      • 12.4.5 Eli Lilly and Company Recent Development
    • 12.5 Johnson & Johnson
      • 12.5.1 Johnson & Johnson Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Breast Cancer Treatment Introduction
      • 12.5.4 Johnson & Johnson Revenue in Breast Cancer Treatment Business (2014-2019)
      • 12.5.5 Johnson & Johnson Recent Development
    • 12.6 Pfizer
      • 12.6.1 Pfizer Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Breast Cancer Treatment Introduction
      • 12.6.4 Pfizer Revenue in Breast Cancer Treatment Business (2014-2019)
      • 12.6.5 Pfizer Recent Development
    • 12.7 AstraZeneca
      • 12.7.1 AstraZeneca Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Breast Cancer Treatment Introduction
      • 12.7.4 AstraZeneca Revenue in Breast Cancer Treatment Business (2014-2019)
      • 12.7.5 AstraZeneca Recent Development
    • 12.8 GlaxoSmithKline
      • 12.8.1 GlaxoSmithKline Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Breast Cancer Treatment Introduction
      • 12.8.4 GlaxoSmithKline Revenue in Breast Cancer Treatment Business (2014-2019)
      • 12.8.5 GlaxoSmithKline Recent Development
    • 12.9 Sun Pharmaceutical Industries
      • 12.9.1 Sun Pharmaceutical Industries Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Breast Cancer Treatment Introduction
      • 12.9.4 Sun Pharmaceutical Industries Revenue in Breast Cancer Treatment Business (2014-2019)
      • 12.9.5 Sun Pharmaceutical Industries Recent Development
    • 12.10 Bayer
      • 12.10.1 Bayer Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Breast Cancer Treatment Introduction
      • 12.10.4 Bayer Revenue in Breast Cancer Treatment Business (2014-2019)
      • 12.10.5 Bayer Recent Development
    • 12.11 Gilead Sciences

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Breast cancer is the one of the most prevalent cancer and among the leading cause of death in cancer patients. According, to WHO 2013 report 50800 women died of breast cancer in 2011. Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast cancer. Although cancer has spread to other parts of the body, but it is treated as breast cancer only. Usually, metastatic breast cancer occurs months or years after completion of treatment for early or locally advanced stages of breast cancer. Metastatic breast cancer cannot be cured. As it has spread to other organs, so it becomes impossible to get rid of all types of cancer. But the treatment of metastatic breast cancer can extend patient’s life with increasing quality of life. Treatment of metastatic breast cancer is influenced by factors such as symptoms, past treatments, cancer cell characteristics and organs affected.
      Metastatic breast cancer treatment market is estimated to be driven by the increasing prevalence of breast cancer and its recurrence. Development of new technologies and increasing awareness among people is expected to drive demand for metastatic breast cancer treatment. Unavailability of effective treatment to cure and side effects related to the treatment can restrict the growth of metastatic breast cancer treatment market. High cost associated with the metastatic breast cancer treatment can also hinder the growth of this market.
      In 2018, the global Breast Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Breast Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Treatment development in United States, Europe and China.

      The key players covered in this study
      F. Hoffmann-La Roche
      Novartis
      Merck
      Eli Lilly and Company
      Johnson & Johnson
      Pfizer
      AstraZeneca
      GlaxoSmithKline
      Sun Pharmaceutical Industries
      Bayer
      Gilead Sciences

      Market segment by Type, the product can be split into
      Chemotherapy
      Radiation Therapy
      Biologic Targeted Therapy
      Breast Surgery
      Hormone Therapy

      Market segment by Application, split into
      Hospitals
      Clinics
      Ambulatory Care Units

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Breast Cancer Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Breast Cancer Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Breast Cancer Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Breast Cancer Treatment . Industry analysis & Market Report on Breast Cancer Treatment is a syndicated market report, published as Global Breast Cancer Treatment Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Breast Cancer Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,014.93
      4,522.40
      6,029.86
      3,501.56
      5,252.35
      7,003.13
      423,423.00
      635,134.50
      846,846.00
      276,594.24
      414,891.36
      553,188.48
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report